Kinetic considerations relating to the use of drug precursors.
作者信息
Martin B K
出版信息
Br J Pharmacol Chemother. 1967 Nov;31(3):420-34. doi: 10.1111/j.1476-5381.1967.tb00409.x.
Abstract
摘要
相似文献
1
Kinetic considerations relating to the use of drug precursors.与药物前体使用相关的动力学考量。
Br J Pharmacol Chemother. 1967 Nov;31(3):420-34. doi: 10.1111/j.1476-5381.1967.tb00409.x.
2
Kinetics of pharmacologic effects.药理效应动力学
Clin Pharmacol Ther. 1966 May-Jun;7(3):362-72. doi: 10.1002/cpt196673362.
3
[Significance of pharmacokinetics in pharmacotherapy and pharmacology].
Folia Med Cracov. 1974;16(3):355-66.
4
Pharmacokinetic principles in pediatric pharmacology.
Pediatr Clin North Am. 1972 Feb;19(1):81-100. doi: 10.1016/s0031-3955(16)32668-2.
5
On the in vivo kinetics of drug action.论药物作用的体内动力学。
Arzneimittelforschung. 1966 Jul;16(7):886-93.
6
The two-compartment open-system kinetic model: a review of its clinical implications and applications.
J Pediatr. 1976 May;88(5):869-73. doi: 10.1016/s0022-3476(76)81135-3.
7
[Pharmacokinetics as a basic pharmacological problem].[作为一个基础药理学问题的药代动力学]
Acta Diabetol Lat. 1969 Sep;6 Suppl 1:59-73.
8
[On the development of quantitative concepts in pharmacology].
Wien Klin Wochenschr. 1969 Apr 18;81(16):285-8.
9
[Utilization of analog computers in the development of dosage forms].[模拟计算机在剂型开发中的应用]
Mitt Dtsch Pharm Ges Pharm Ges DDR. 1971 Sep;41(9):205-47.
10
Drug input optimization: bioavailability-effected time-optimal control of multiple, simultaneous, pharmacological effects and their interrelationships.
J Pharm Sci. 1972 Dec;61(12):1941-52. doi: 10.1002/jps.2600611212.
引用本文的文献
1
Understanding the pharmacokinetics of prodrug and metabolite.了解前药和代谢物的药代动力学。
Transl Clin Pharmacol. 2018 Mar;26(1):1-5. doi: 10.12793/tcp.2018.26.1.1. Epub 2018 Mar 16.
本文引用的文献
1
Drug latentiation.药物潜伏化
J Med Pharm Chem. 1959 Oct;1:467-500. doi: 10.1021/jm50006a005.
2
3
EXCRETION AND THE ACCRUAL OF DRUG METABOLITES.药物代谢产物的排泄与蓄积
Nature. 1963 Dec 28;200:1296-7. doi: 10.1038/2001296a0.
4
Dosage schedule and pharmacokinetics in chemotherapy.化疗中的给药方案与药代动力学
J Am Pharm Assoc Am Pharm Assoc. 1960 May;49:311-3.
5
Sulfaethylthiadiazole. IV. Steady state blood concentration and urinary excretion data following repeated oral doses.磺胺乙噻二唑。IV. 多次口服给药后的稳态血药浓度和尿排泄数据。
J Am Pharm Assoc Am Pharm Assoc. 1958 Oct;47(10):753-6. doi: 10.1002/jps.3030471019.
6
Chemical aspects of selective toxicity.选择性毒性的化学方面。
Nature. 1958 Aug 16;182(4633):421-2. doi: 10.1038/182421a0.
7
Proguanil, the isolation of a metabolite with high antimalarial activity.氯胍，一种具有高抗疟活性代谢物的分离。
Br J Pharmacol Chemother. 1953 Mar;8(1):93-7. doi: 10.1111/j.1476-5381.1953.tb00758.x.
8
Kinetic considerations relating to the accrual and elimination of drug metabolites.与药物代谢物的累积和消除相关的动力学考量。
Br J Pharmacol Chemother. 1967 Feb;29(2):136-49. doi: 10.1111/j.1476-5381.1967.tb01947.x.
9
Blood levels of drug at the equilibrium state after multiple dosing.多次给药后达到平衡状态时药物的血药浓度。
Nature. 1965 Sep 18;207(5003):1301-2. doi: 10.1038/2071301a0.
10
The role of the therapeutic regimen in dosage design. II.治疗方案在剂量设计中的作用。II.
Chemotherapy. 1965;10(3):129-44. doi: 10.1159/000220402.
Zotero 插件